ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging

Sharmila Dorbala¹, Yukio Ando², Sabahat Bokhari³, Angela Dispenzieri⁴, Rodney H Falk⁵, Victor A Ferrari⁶, Marianna Fontana⁷, Olivier Gheysens⁸, Julian D Gillmore⁷, Andor W J M Glaudemans⁹, Mazen A Hanna¹⁰, Bouke P C Hazenberg¹¹, Arnt V Kristen¹², Raymond Y Kwong⁵, Mathew S Maurer³, Giampaolo Merlini^{13

14}, Edward J Miller¹⁵, James C Moon⁷, Venkatesh L Murthy¹⁶, C Cristina Quarta⁷, Claudio Rapezzi¹⁷, Frederick L Ruberg¹⁸, Sanjiv J Shah¹⁹, Riemer H J A Slart⁹, Hein J Verberne²⁰, Jamieson M Bourque²¹

Affiliations

¹ Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. sdorbala@bwh.harvard.edu.
² Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
³ Columbia University Medical Center/New York Presbyterian Hospital, Columbia University, New York, NY, USA.
⁴ Division of Hematology, Division of Cardiovascular Diseases, and Department of Radiology, Division of Nuclear Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
⁵ Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
⁶ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁷ Division of Medicine, National Amyloidosis Centre, University College London, London, UK.
⁸ Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, Leuven, Belgium.
⁹ Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
¹⁰ Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
¹¹ Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
¹² Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
¹³ Amyloidosis Research and Treatment Center, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
¹⁴ Department of Molecular Medicine, University of Pavia, Pavia, Italy.
¹⁵ Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
¹⁶ Frankel Cardiovascular Center, Michigan Medicine, Ann Arbor, MI, USA.
¹⁷ Cardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater-University of Bologna, Bologna, Italy.
¹⁸ Amyloidosis Center and Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
¹⁹ Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
²⁰ Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
²¹ Departments of Medicine and Radiology, Cardiovascular Imaging Center, University of Virginia, Charlottesville, VA, USA.

PMID: 31468376
DOI: 10.1007/s12350-019-01760-6

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging

Sharmila Dorbala et al. J Nucl Cardiol. 2019 Dec.

. 2019 Dec;26(6):2065-2123.

doi: 10.1007/s12350-019-01760-6.

Authors

Affiliations

¹ Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. sdorbala@bwh.harvard.edu.
² Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
³ Columbia University Medical Center/New York Presbyterian Hospital, Columbia University, New York, NY, USA.
⁴ Division of Hematology, Division of Cardiovascular Diseases, and Department of Radiology, Division of Nuclear Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
⁵ Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
⁶ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁷ Division of Medicine, National Amyloidosis Centre, University College London, London, UK.
⁸ Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, Leuven, Belgium.
⁹ Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
¹⁰ Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
¹¹ Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
¹² Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
¹³ Amyloidosis Research and Treatment Center, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
¹⁴ Department of Molecular Medicine, University of Pavia, Pavia, Italy.
¹⁵ Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
¹⁶ Frankel Cardiovascular Center, Michigan Medicine, Ann Arbor, MI, USA.
¹⁷ Cardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater-University of Bologna, Bologna, Italy.
¹⁸ Amyloidosis Center and Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
¹⁹ Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
²⁰ Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
²¹ Departments of Medicine and Radiology, Cardiovascular Imaging Center, University of Virginia, Charlottesville, VA, USA.

PMID: 31468376
DOI: 10.1007/s12350-019-01760-6

Erratum in

Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. Dorbala S, et al. J Nucl Cardiol. 2021 Aug;28(4):1761-1762. doi: 10.1007/s12350-021-02711-w. J Nucl Cardiol. 2021. PMID: 34259978 No abstract available.

No abstract available

PubMed Disclaimer

References

1. Circ Cardiovasc Imaging. 2013 Jan 1;6(1):34-9 - PubMed
1. Heart Lung Circ. 2017 Nov;26(11):1183-1190 - PubMed
1. JACC Heart Fail. 2014 Aug;2(4):358-67 - PubMed
1. Eur J Haematol. 2007 Dec;79(6):494-500 - PubMed
1. Am J Cardiol. 2002 May 1;89(9):1067-71 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging

Affiliations

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging

Authors

Affiliations

Erratum in

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Medical